tiprankstipranks
Amexdrug Corporation (AXRX)
OTHER OTC:AXRX
US Market

Amexdrug (AXRX) Financial Statements

Compare
25 Followers

Amexdrug Financial Overview

Amexdrug's market cap is currently $338.82K. The company's EPS TTM is $0; its P/E ratio is 1,580.00; Amexdrug is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 12Dec 11Dec 10Dec 09Dec 08
Income Statement
Total Revenue
Gross Profit$ 1.01M$ 995.75K$ 962.68K$ 721.81K$ 454.51K
Operating Income$ 195.85K$ 221.31K$ 290.43K$ 55.70K$ 33.32K
EBITDA$ 217.26K$ 220.63K$ 299.44K$ 58.72K$ 44.83K
Net Income$ 82.03K$ 100.65K$ 189.06K$ 18.35K$ 12.33K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 2.41M$ 1.60M$ 1.34M$ 798.41K$ 709.40K
Total Debt$ 1.09M$ 631.90K$ 418.61K$ 312.90K$ 200.49K
Net Debt$ 669.81K$ 40.32K$ -32.74K$ 184.23K$ 93.13K
Total Liabilities$ 1.98M$ 1.25M$ 1.09M$ 734.81K$ 654.86K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -619.39K$ -179.47K$ 222.75K$ -73.12K$ -195.56K
Operating Cash Flow$ -160.80K$ -137.02K$ 226.78K$ -62.75K$ -193.71K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Amexdrug Earnings and Revenue History

Amexdrug Debt to Assets

Amexdrug Cash Flow

Amexdrug Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis